Clas Sonesson

Chief Scientific Officer at IRLAB Therapeutics

Dr. Clas Sonesson started his career at AkzoNobel (former Berol Kemi 1986-1989) as organic chemist developing new surfactants for enhanced oil recovery in the North Sea. In 1989, he was appointed a position as medicinal chemist in Nobel Laureate Professor Arvid Carlsson’s research group at the Department of Pharmacology, Göteborg University. In 1990, he became a Ph.D. student (1990-1995) and between 1995 and 2000 he was managing research collaborations between the university and pharma industry partners. In 1998, he co-founded Carlsson Research and between 1998 and 2002 he served as member of the board of directors at Carlsson Research. In 2000, he was appointed Head of Medicinal Chemistry and in 2002 Director of Chemistry and IP (2002-2006). During this period, Clas was also responsible for CMC in three development projects which also continued after NeuroSearch’s acquisition of Carlsson Research. In 2006, (2006-2009) Clas was appointed Director of Chemistry and IP at NeuroSearch Sweden. In 2009, Clas was appointed Head of Discovery (NeuroSearch Sweden 2009-2011) and thereafter served as VP, Chemistry & IP (NeuroSearch, 2011-2012). In 2013, Clas co-founded IRLAB. Clas holds a Ph.D. in Medicinal Chemistry.

Holdings: 748,589 Class A shares and 8,946 series B shares.


Org chart